Celebrex is
relatively new product, which is indicated for the temporary
relief of osteoarthritis and Rheumatoid arthritis. Celebrex
has demonstrated significant reduction in joint pain compared
to placebo. In clinical studies, Celebrex was found to cause a
significant reduction in pain within the first 24-48 hours of
initial dosage. Celebrex is the first in a new line of drugs
designed to fight arthritis know as COX-2 inhibitors. Compared
to other treatments Celebrex has a very low side effect
profile, and has very little risk of G.I. bleeding
Articles about
Celebrex
Investigational Drug Found as Effective as NSAIDs
for Arthritis Pain
November 16, 1998
Getting
a Grip on Pain - A new drug may revolutionize arthritis
care
December 14, 1998
First COX-2 Inhibitor Approved for OA and
RA
January 4, 1999
FDA
Approves Celebrex for Arthritis
December 31, 1998
New
Family of Pain Killers Approved
January 7, 1999
Arthritis enzyme linked to
diseases
February 2, 1999
Celebrex Approved By FDA
March 1999
Celebrex
Approved In Canada For Arthritis
April 15,
1999
Arthritis Drug Celebrex: Safe or
Suspect?
June 25,
1999
Celebrex and Vioxx
Approved
Sept, 1999
| 
